Liu F, Wang X, Duan J, Hou Z, Wu Z, Liu L
Adv Sci (Weinh). 2022; 9(22):e2104823.
PMID: 35652200
PMC: 9353462.
DOI: 10.1002/advs.202104823.
Yang Y, Santos D, Pantano L, Knipe R, Abe E, Logue A
Am J Respir Cell Mol Biol. 2022; 67(1):36-49.
PMID: 35377835
PMC: 9798384.
DOI: 10.1165/rcmb.2021-0428OC.
Yoo S, Sinha A, Yang D, Altorki N, Tandon R, Wang W
Nat Commun. 2022; 13(1):1592.
PMID: 35332150
PMC: 8948234.
DOI: 10.1038/s41467-022-29230-7.
Alkhateeb K, Crane J, Sak M, Jorgensen C, ODonnell J, Zumbar C
Diagn Pathol. 2021; 16(1):98.
PMID: 34706741
PMC: 8549328.
DOI: 10.1186/s13000-021-01158-4.
Wu P, Wang C, Hsieh M, Lee C, Wang P, Lin C
Int J Med Sci. 2021; 18(11):2457-2465.
PMID: 33967624
PMC: 8100634.
DOI: 10.7150/ijms.58516.
OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.
Kim H, Kim J
Int J Mol Sci. 2021; 22(4).
PMID: 33669244
PMC: 7919836.
DOI: 10.3390/ijms22041936.
Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition.
Huang M, Feng X, Su D, Wang G, Wang C, Tang M
Oncogene. 2020; 39(21):4312-4322.
PMID: 32300176
PMC: 7291820.
DOI: 10.1038/s41388-020-1296-2.
Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers.
Gomaa A, Peng D, Chen Z, Soutto M, Abouelezz K, Corvalan A
Sci Rep. 2019; 9(1):16970.
PMID: 31740746
PMC: 6861278.
DOI: 10.1038/s41598-019-53174-6.
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies.
Siddiqi T, Frankel P, Beumer J, Kiesel B, Christner S, Ruel C
Leuk Lymphoma. 2019; 61(2):309-317.
PMID: 31617432
PMC: 6982547.
DOI: 10.1080/10428194.2019.1672052.
IgG based immunome analyses of breast cancer patients reveal underlying signaling pathways.
Gyurjan I, Rosskopf S, Coronell J, Muhr D, Singer C, Weinhausel A
Oncotarget. 2019; 10(37):3491-3505.
PMID: 31191821
PMC: 6544406.
DOI: 10.18632/oncotarget.26834.
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species.
Wood F, Shepherd S, Hayes A, Liu M, Grira K, Mok Y
Eur J Pharm Sci. 2019; 139:104899.
PMID: 30953752
PMC: 6892276.
DOI: 10.1016/j.ejps.2019.04.004.
Aurora A inhibition limits centrosome clustering and promotes mitotic catastrophe in cells with supernumerary centrosomes.
Navarro-Serer B, Childers E, Hermance N, Mercadante D, Manning A
Oncotarget. 2019; 10(17):1649-1659.
PMID: 30899434
PMC: 6422193.
DOI: 10.18632/oncotarget.26714.
The functional diversity of Aurora kinases: a comprehensive review.
Willems E, Dedobbeleer M, Digregorio M, Lombard A, Lumapat P, Rogister B
Cell Div. 2018; 13:7.
PMID: 30250494
PMC: 6146527.
DOI: 10.1186/s13008-018-0040-6.
Controlling the master-upstream regulation of the tumor suppressor LKB1.
Kullmann L, Krahn M
Oncogene. 2018; 37(23):3045-3057.
PMID: 29540834
DOI: 10.1038/s41388-018-0145-z.
Network analysis revealed aurora kinase dysregulation in five gynecological types of cancer.
Suman S, Mishra A
Oncol Lett. 2018; 15(1):1125-1132.
PMID: 29391900
PMC: 5769420.
DOI: 10.3892/ol.2017.7368.
MYC Deregulation in Primary Human Cancers.
Kalkat M, De Melo J, Hickman K, Lourenco C, Redel C, Resetca D
Genes (Basel). 2017; 8(6).
PMID: 28587062
PMC: 5485515.
DOI: 10.3390/genes8060151.
Characterization of Aurora A and Its Impact on the Effect of Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer.
Kuang P, Chen Z, Wang J, Liu Z, Wang J, Gao J
Transl Oncol. 2017; 10(3):367-377.
PMID: 28431392
PMC: 5397579.
DOI: 10.1016/j.tranon.2017.02.010.
Mechanisms for nonmitotic activation of Aurora-A at cilia.
Korobeynikov V, Deneka A, Golemis E
Biochem Soc Trans. 2017; 45(1):37-49.
PMID: 28202658
PMC: 5860652.
DOI: 10.1042/BST20160142.
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
Yang N, Wang C, Wang Z, Zona S, Lin S, Wang X
Oncogene. 2017; 36(24):3428-3440.
PMID: 28114286
PMC: 5485180.
DOI: 10.1038/onc.2016.490.
Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.
Treekitkarnmongkol W, Katayama H, Kai K, Sasai K, Jones J, Wang J
Carcinogenesis. 2016; 37(12):1180-1189.
PMID: 27624071
PMC: 5137261.
DOI: 10.1093/carcin/bgw097.